Double-Blind Randomised Controlled Trial of Lesogaberan in Chronic Cough Patients This means patients will take Lesogaberan and a dummy drug (called placebo) in a random order. During the study neither the study doctor or patient will know whether they are taking Lesogaberan or placebo as the tablets will look identical.
- Registry ID
- EUCTR2014-005074-11
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- University Hospital South Manchester NHS Foundation Trust
- Start date
- 2015-04-29
- Completion date
- 2017-08-30
- Last update
- 2026-08-16
Conditions
Summary
To evaluate the effect of 2 weeks of Lesogaberan treatment compared with 2 weeks of placebo treatment on 24 hour cough frequency. Lay description: To test what effect a drug called Lesogaberan has on how much a person coughs in a 24 hour period compared to if that person was taking a dummy drug with no active ingredients (called placebo).
Locations
View on source registry